+919405117673
Dasatinib Tablets 50mg/70mg/100mg and Supplier Verification for Pharmaceutical Procurement in Nagpur

A procurement team must confirm more than the milligram strength before accepting dasatinib tablets: the prescribed regimen, destination-market authorization, batch traceability and supplier credentials all affect whether the shipment is usable. By the end, you will have a practical checklist for matching the pack to the order, validating documents and screening a Nagpur-based exporter before payment.

Key takeaways

  • Match 50 mg, 70 mg or 100 mg tablets to the written regimen.
  • Reconcile strength, batch number, expiry date and destination-market label.
  • Ask for the Nagpur supplier’s licence copy, GST details and company address.
  • Validate the certificate of analysis against the batch and product specification.

Match the tablet strength to the written regimen

Match the prescribed strength and regimen, not the tablet count in a supplier’s quotation. Confirm the active ingredient, indication, dose per administration, dosing frequency and destination-market label before accepting dasatinib 50 mg tablets, dasatinib 70 mg tablets or dasatinib 100 mg tablets.

Use this procurement check:

  • Compare the written prescription with the quoted strength and total daily dose. For newly diagnosed chronic-phase CML, the U.S. reference label uses 100 mg once daily; accelerated-phase or blast-phase CML and Philadelphia-chromosome-positive ALL use 140 mg once daily.
  • Do not assume that two 70 mg tablets replace a 140 mg regimen, or that a 100 mg tablet matches every CML prescription. Ask the prescriber or pharmacist to confirm any multiple-tablet schedule.
  • Check the destination country’s approved label. Available strengths and authorized indications differ by jurisdiction, so a supplier offering only 50 mg, 70 mg and 100 mg tablets does not prove that each strength is lawful or suitable for your market.
  • Reject any instruction to crush, chew, disperse or split tablets unless the responsible pharmacist and product information specifically authorize it. Dasatinib is a high-potency oncology medicine, and manipulation creates dose-integrity and hazardous-drug handling risks.

Record the confirmed strength, regimen, dosage form, manufacturer and authorization reference in the purchase file. A certificate of analysis cannot make an incorrect strength safe, and pack size cannot replace written clinical confirmation.

Reconcile every pack detail before accepting stock

Accept stock only after the physical pack matches the quotation, commercial invoice, packing list, airway bill, and batch-specific release records. Inspect both the outer carton and the primary blister or bottle; a certificate of analysis alone does not prove genuine stock, legal sale in your country, or correct storage after release.

CheckPhysical evidenceDocument match
Active ingredient and strengthDasatinib and 50 mg, 70 mg or 100 mg stated on carton, blister and labelQuotation, invoice and certificate of analysis
Batch number, manufacturing date and expiry dateIdentical, legible details on every packCertificate of analysis, release document and shipping records
Tablet count and dosage formStated count and tablet form match the ordered presentationQuotation, packing list and invoice
Manufacturer and licence informationName, address and manufacturing-licence details printed on the labelQuotation and release documentation
Seal and conditionIntact tamper-evident seal, undamaged carton, dry blisters and no altered printingInspection photographs and receipt report
Storage and transportLabelled storage range, transport condition and temperature-logger recordShipping instructions and logistics record

Reject or quarantine stock when any identifier differs, a seal is broken, labels are over-stickered without traceable explanation, or the shipment lacks a documented chain of custody from licensed source to exporter. Compare photographs and a physical sample from the same shipment, then record discrepancies before signing receipt.

Ask for replacement or recall instructions in writing.

Verify a Nagpur supplier’s legal and commercial identity

Before sending payment, establish that the party named in the quotation is both a real business and an authorised medicine wholesaler. GST registration and company incorporation confirm commercial identity; neither authorises wholesale handling of prescription medicines.

1. Match the legal name, registered address and GSTIN on the quotation, tax invoice and bank details. Reject payment to an account held by an unrelated person or company. Obtain the authorised signatory’s name and verify the business-domain email independently.

2. Request the current Maharashtra drug licence and confirm the licence holder, premises or warehouse address, licence number, product categories and validity with Maharashtra’s drug-control authority. A residential address, expired licence or licence issued to another entity is a stop sign.

3. Complete IEC exporter verification through the Directorate General of Foreign Trade. Match the IEC legal name and address with the commercial invoice, packing list and shipping documents; any mismatch requires resolution before dispatch.

4. Treat a product listing, GMP certificate or manufacturing authorisation as insufficient proof of destination-market legality. Check the destination regulator’s marketing authorisation, approved pack presentation and the local importer or wholesaler’s authorisation.

5. Ask for a storage record matching the labelled 20–25°C condition, including permitted 15–30°C excursions, rather than accepting “room temperature.” Confirm the listing also identifies manufacturer, batch and expiry details.

Apply this Nagpur pharmaceutical supplier verification process to Cordium Pharmaceuticals Pvt Ltd or any competing source; a credible company must withstand the same document and identity checks. Keep copies of every licence, verification result, quotation and bank confirmation in the procurement file.

Related products

Dasatib Tablets – Product Description, Uses, Benefits and Side Effects

Oncology Medicine

Dasatib Tablets – Product Description, Uses, Benefits and Side Effects

Product Overview Dasatib Tablets 50 mg, 70 mg and 100 mg contain dasatinib, a prescription medicine belonging to the tyrosine kinase inhibitor (TKI)...

View product →
Spnib Tablets – Dasatinib Medicine for Blood Cancer Treatment in India

Oncology Medicine

Spnib Tablets – Dasatinib Medicine for Blood Cancer Treatment in India

Product Description Spnib Tablets contain Dasatinib, a prescription medicine belonging to the tyrosine kinase inhibitor class.

View product →

Request export documents and validate the certificate of analysis

Shipment traceability rests on matching the same legal exporter, product, batch and quantity across every record; a pro forma invoice is an offer, not proof of dispatch. Require these records before payment or release:

  • Pro forma invoice showing the exact dasatinib strength, dosage form, quantity, price, Incoterm, exporter and buyer.
  • Commercial invoice carrying the exporter’s legal name, address, DGFT-issued Importer-Exporter Code, invoice number, date and shipped quantity.
  • Packing list matching carton count, pack size, batch numbers and gross and net weight.
  • Purchase invoice or batch-specific release document linking the licensed wholesaler or manufacturer to the exporter.
  • Transport record, storage evidence, and a named contact for recalls and returns.
DocumentCheckFailure signal
Commercial invoiceLegal name and address match the IEC, packing list and shipping recordDifferent entity or bank beneficiary
Packing listCartons, quantities and batch numbers match the shipmentBatch omitted or count differs
Certificate of analysisProduct, strength, batch, manufacturing date and expiry match the offered packGeneric, altered or different batch

Certificate of analysis validation starts with the physical stock, not the PDF. Compare the certificate’s batch number, manufacturing date, expiry, manufacturer, dosage form and reported tests with clear pack photographs and a sample from the same shipment.

Confirm the issuing laboratory or manufacturer through an independent contact, and request the signed, dated report and specification or release reference.

An intact primary or secondary label remains essential; an invoice or certificate cannot replace it. A certificate proves only the reported tests for that batch, not destination-country authorization, genuine custody or correct storage. Quarantine stock when records leave unexplained gaps.

Resolve authorization, logistics and replacement terms before ordering

A valid GMP certificate does not prove that the exact 50 mg, 70 mg or 100 mg tablets may be sold in your destination country. Before payment, obtain written answers and documents for these questions:

  • What is the destination-country marketing authorization number for this manufacturer, strength, indication and pack presentation?
  • Is the local importer or wholesaler licensed for this product, and who will act as the responsible importer?
  • What remaining shelf life will exist on delivery, and will the supplier reject batches below your minimum?
  • Does the product have a cold-chain requirement? If not, will transport remain within the labeled 20–25°C range, with permitted excursions of 15–30°C and a downloadable temperature record?
  • Who bears the cost and risk if cartons arrive wet, crushed, tampered with or short?
  • What are the replacement terms for a shortage, damage, failed temperature record or laboratory discrepancy?
  • How will you receive a recall notice, identify affected batches and return or destroy stock?

Use the answers to compare the proposed arrangement with a defensible order:

IssueAcceptable evidenceStop or hold the order when
AuthorizationDestination registration, approved indications, pack and importer licenceOnly Indian GMP or manufacturing documents are supplied
TransportQualified carrier, logger record and written excursion procedure“Ambient” is the only assurance
Shortage or damageCredit or replacement terms naming timelines and responsibilityLiability is undefined
RecallBatch-level notification, return route and contactNo documented recall process exists

A temperature excursion requires quality hold and stability-based disposition, not automatic release.

Frequently asked questions

  • How do you match dasatinib tablet strength to the written regimen?

    Compare the prescribed active ingredient, dose per administration, dosing frequency and destination-market label with the quoted 50 mg, 70 mg or 100 mg strength. Do not approve stock based only on tablet count.

  • Which pack details should you reconcile before accepting dasatinib stock?

    Check the product name, strength, dosage form, pack size, batch number, manufacturing date, expiry date, manufacturer, seal condition and destination-market label against the quotation and shipping documents.

  • How can you verify a Nagpur pharmaceutical supplier’s identity?

    Request the supplier’s legal name, registered address, GSTIN, company registration details, pharmaceutical wholesale or manufacturing licence copy and bank-account name. Confirm that the documents identify the same contracting entity.

  • Which export documents should you request for dasatinib procurement?

    Request the commercial invoice, packing list, certificate of analysis, certificate of origin when required, shipping documents and any destination-country import or product documentation required by the buyer’s authority.

  • How do you validate a dasatinib certificate of analysis?

    Match the certificate’s product name, strength, dosage form, batch number, test dates, specifications, results, units, authorised signatory and manufacturer details to the physical pack and purchase documents.

Related products

Dasanat Tablets in UAE – Dasatinib Tablets for Blood Cancer Treatment

Oncology Medicine

Dasanat Tablets in UAE – Dasatinib Tablets for Blood Cancer Treatment

Product Description Dasanat Tablets contain dasatinib, an oral prescription medicine belonging to the tyrosine kinase inhibitor class.

Dasatrue Tablets: Dasatinib Medicine for Philadelphia Chromosome-Positive Leukemia

Oncology Medicine

Dasatrue Tablets: Dasatinib Medicine for Philadelphia Chromosome-Positive Leukemia

Product Description Dasatrue Tablets contain dasatinib, a prescription tyrosine kinase inhibitor used under specialist medical supervision for...

Daslemia Tablets – Dasatinib Treatment for Certain Blood Cancers

Oncology Medicine

Daslemia Tablets – Dasatinib Treatment for Certain Blood Cancers

Daslemia Tablets contain dasatinib, a targeted anticancer medicine belonging to the tyrosine kinase inhibitor class.

Nov 16th, 2026 7:01 PM